Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Teriflunomide (Aubagio®) for the treatment of multiple sclerosis.
Costs of Illness of Multiple Sclerosis In Sweden - A Population-Based Register Study.
Monoclonal Antibodies for Multiple Sclerosis Treatment.
Diffusion-weighted imaging and demyelinating diseases: new aspects of an old advanced sequence.
Comprehensive Identification of Long Non-coding RNAs in Purified Cell Types from the Brain Reveals Functional LncRNA in OPC Fate Determination.
Protective effects of 27- and 24-hydroxycholesterol against staurosporine-induced cell death in undifferentiated neuroblastoma SH-SY5Y cells.
Loss of astrocytic leptin signaling worsens experimental autoimmune encephalomyelitis.
Valuing the Endangered Species Antirrhinum lopesianum: Neuroprotective Activities and Strategies for in vitro Plant Propagation.
Systematic review and meta-analysis of interventions for depression and anxiety in persons with multiple sclerosis.
Isolated anti-β2-glycoprotein I antibodies in neurology: a frontier syndrome between multiple sclerosis and antiphospholipid syndrome?
Randomised multicentre trial on safety and efficacy of rivastigmine in cognitively impaired multiple sclerosis patients.
A rare case of multiple sclerosis and McArdle disease.
Pituitary apoplexy presented with optic neuritis.
The node of Ranvier in CNS pathology.
Blood pressure normalization post-jugular venous balloon angioplasty.
Changes in brain atrophy indices in patients with relapsing-remitting multiple sclerosis treated with natalizumab.
The CIITA genetic polymorphism rs4774*C in combination with the HLA-DRB1*15:01 allele as a putative susceptibility factor to multiple sclerosis in Brazilian females.
Patient reported outcomes measures in neurogenic bladder and bowel: A systematic review of the current literature.
Features of Virchow-Robin spaces in newly diagnosed multiple sclerosis patients.
How to make an oligodendrocyte.
Disease-modifying drugs for multiple sclerosis in pregnancy: A systematic review.
Diagnostic tools for assessment of urinary dysfunction in MS patients without urinary disturbances.
Functional brain network analysis using minimum spanning trees in Multiple Sclerosis: An MEG source-space study.
[Pelvic floor muscles training, electrical stimulation, bladder training and lifestyle interventions to manage lower urinary tract dysfunction in multiple sclerosis: A systematic review].
Clinically silent PML and prolonged immune reconstitution inflammatory syndrome in a patient with multiple sclerosis treated with natalizumab.
Pages
« first
‹ previous
…
431
432
433
434
435
436
437
438
439
…
next ›
last »